Dimensional Fund Advisors LP
- SEC CIK
- 0000354204
- Latest filing
- Aug 11, 2026
TARS holding history
Tarsus Pharmaceuticals, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TARS overviewAll 13F holders of TARSFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −91,171−100.0% | Sold out | Holders |
| Q3 2025 | 91,171 | $5.42M | <0.1% | −963−1.0% | Reduced | Holders |
| Q2 2025 | 92,134 | $3.73M | <0.1% | −216,096−70.1% | Reduced | Holders |
| Q1 2025 | 308,230 | $15.8M | <0.1% | −33,075−9.7% | Reduced | Holders |
| Q4 2024 | 341,305 | $18.9M | <0.1% | −62,658−15.5% | Reduced | Holders |
| Q3 2024 | 403,963 | $13.3M | <0.1% | −2,936−0.7% | Reduced | Holders |
| Q2 2024 | 406,899 | $11.1M | <0.1% | −17,931−4.2% | Reduced | Holders |
| Q1 2024 | 424,830 | $15.4M | <0.1% | −5,297−1.2% | Reduced | Holders |
| Q4 2023 | 430,127 | $8.71M | <0.1% | +74,444+20.9% | Added | Holders |
| Q3 2023 | 355,683 | $6.32M | <0.1% | +99,223+38.7% | Added | Holders |
| Q2 2023 | 256,460 | $4.63M | <0.1% | +20,930+8.9% | Added | Holders |
| Q1 2023 | 235,530 | $2.96M | <0.1% | +35,854+18.0% | Added | Holders |
| Q4 2022 | 199,676 | $2.93M | <0.1% | +57,469+40.4% | Added | Holders |
| Q3 2022 | 142,207 | $2.43M | <0.1% | +29,232+25.9% | Added | Holders |
| Q2 2022 | 112,975 | $1.65M | <0.1% | +84,120+291.5% | Added | Holders |
| Q1 2022 | 28,855 | $485.0K | <0.1% | +19,865+221.0% | Added | Holders |
| Q4 2021 | 8,990 | $202.0K | <0.1% | +8,990 | New | Holders |